Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Porvair ( (GB:PRV) ) is now available.
Porvair plc has announced significant board changes, appointing Lisa Anson as a Non-Executive Director effective 1 October 2025. Anson, with a robust background in the pharmaceutical and biotech industry, will join several committees within Porvair, bringing her extensive leadership and commercial experience. Additionally, Sally Martin will retire from the board after nine years, with Sheena Mackay stepping up as Senior Independent Director and taking on additional responsibilities. These changes are poised to impact Porvair’s governance and strategic direction positively.
The most recent analyst rating on (GB:PRV) stock is a Hold with a £783.00 price target. To see the full list of analyst forecasts on Porvair stock, see the GB:PRV Stock Forecast page.
Spark’s Take on GB:PRV Stock
According to Spark, TipRanks’ AI Analyst, GB:PRV is a Neutral.
Porvair’s strong financial performance is the most significant factor, reflecting robust growth and profitability. Technical analysis presents mixed signals, with some bearish momentum indicators. Valuation is fair, with a reasonable P/E ratio and modest dividend yield. The absence of earnings call and corporate events data limits further insights.
To see Spark’s full report on GB:PRV stock, click here.
More about Porvair
Porvair plc is a group of specialist filtration, laboratory, and environmental technology businesses. It designs and manufactures bespoke consumable filtration products for niche filtration markets and operates in three divisions: Aerospace & Industrial, Laboratory, and Metal Melt Quality.
Average Trading Volume: 110,241
Technical Sentiment Signal: Buy
Current Market Cap: £330.3M
Find detailed analytics on PRV stock on TipRanks’ Stock Analysis page.